Using blood conservation technique during heart surgery to assess kidney function
Official title: Effect of Low-volume Fluid Replacement Strategy During Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels: an Acute Kidney Injury Biomarker
Run by University of Maryland, Baltimore · NCT05349292 · Data updated 2026-11-12
This study is testing if a blood-saving technique during heart surgery can help improve kidney function in patients while also reducing the need for blood transfusions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | January 31, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 1, 2026 |
| Trial ID | NCT05349292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 undergoing elective CABG surgery with a predicted cardiopulmonary bypass duration of less than 2 hours.
✕Probably not a fit
Patients with renal insufficiency, significant heart or lung diseases, or those requiring emergency surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the effects of acute normovolemic hemodilution (ANH) on urine neutrophil gelatinase-associated lipocalin levels in patients undergoing elective coronary artery bypass graft (CABG) surgery. A total of 50 adult patients under 70 years old will be randomly assigned to receive either ANH or standard care without ANH during their surgery. The study aims to determine if ANH can improve kidney function indicators while reducing the need for blood transfusions. Exclusion criteria include patients with renal insufficiency, significant comorbidities, or those undergoing emergency surgeries.
Why it matters
Potential benefit: If successful, this approach could lead to improved kidney function outcomes and reduced blood transfusion needs for patients undergoing heart surgery.
How similar studies have gone: Previous studies have shown improvements in blood transfusion rates with similar techniques, but this specific approach is being evaluated for the first time regarding kidney function.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Elective Coronary Artery Bypass Graft Surgery * Age 18-70 years * Anticipated Cardiopulmonary Bypass Duration less than 2 hours * Weight greater than 70kg * Hemoglobin greater than 12 g/dL Exclusion Criteria: * Emergency and redo cardiac surgery * Renal insufficiency with serum creatinine greater than 1.25 mg/dL and/ or estimated GFR less than 60 mL/min/1.73 m2 * Heart Failure with EF \<40% * Hepatic disease * Pulmonary Disease, including pulmonary hypertension * Inherited or Acquired Bleeding Disease
Where it's running
-
University of Maryland Medical Center
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Patrick Odonkor, MD — University of Maryland, Baltimore
- Study coordinator: Patrick Odonkor, MD
- Email: podonkor@som.umaryland.edu
- Phone: 4103286120
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
-
Restarting RAS inhibitors after AKI: a quick test in hospitalized adults
This pilot study tests whether restarting renin-angiotensin system inhibitors early after acute kidney injury is feasible and safe in hospitalized adults already using these medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.